Abstract:Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are commonly used antihypertensive drugs. However, the impact that the use of ACEI and ARB drugs will have on the survival of patients with hypertension and cancer is still unclear. Therefore, the present study aimed to investigate the effects of ACEI and ARB use on the survival of patients with cancer. The Embase, PubMed and Web of Science databases were used to systematically analyze the survival of hypertensive patients with cancer treated with ACEIs or ARBs. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to evaluate the association between ACEI and ARB use and patient survival. The relationship between the survival of patients with certain types of cancer and ACEI and ARB use was evaluated using the calculated HRs. Patients with ovarian, pancreatic, prostate, hepatocellular, lung, esophageal, gastric, colon, nasopharyngeal, head and neck tumors, gallbladder and rectal cancers that used ACEI and ARB analogs had significantly increased survival times, except for patients with breast cancer (HR, 1.04; 95% CI, 0.90-1.19; P<0.01) and uroepithelial carcinoma (HR, 1.15; 95% CI, 0.69-1.94; P<0.01), who had significantly decreased survival times, when compared with patients who did not use these drugs. Analysis of the relationship between the use of ACEIs or ARBs alone or in combination on the overall survival of hypertensive patients with cancer demonstrated that the use of ACEIs alone (HR, 1.00; 95% CI, 0.93-1.08; P<0.01) did not have a significant effect on the survival of these patients. By contrast, the survival time was increased in hypertensive patients with cancer who used either ARBs alone (HR, 0.89; 95% CI, 0.84-0.94; P<0.01) or a combination of ACEIs and ARBs (HR, 0.84; 95% CI, 0.78-0.91; P<0.01). The present meta-analysis demonstrated the potential effects of ACEI and ARB use on the overall survival of patients with cancer. Therefore, investigation of the underlying mechanisms of action of ACEIs and ARBs, as well as the identification of specific groups of patients who may benefit from these interventions, could potentially lead to novel therapeutic options and improve the prognosis of patients with cancer in the future.

Effects of Antihypertensive Drugs Use on Risk and Prognosis of Colorectal Cancer: A Meta-Analysis of 37 Observational Studies

Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis

Association Between Family History and Prognosis of Patients with Colorectal Cancer: a Systematic Review and Meta-Analysis.

Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies

Effects of ACEI/ARB Agent on the Prognosis of Patients with Advanced Gastric Cancer Complicated with Hypertension

Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis

Impact of ACEI/ARB use on the survival of hypertensive patients with cancer: A meta‑analysis

Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study

Use of Antihypertensive Medications and Survival of Breast, Colorectal, Lung, or Stomach Cancer.

The Relationship Between Diabetes And Colorectal Cancer Prognosis: A Meta-Analysis Based On The Cohort Studies

Abstract 5518: Use of antihypertensive drugs and the risk of cancer, findings of a population-based cohort study in Shanghai

Metformin Is Associated With Slightly Reduced Risk Of Colorectal Cancer And Moderate Survival Benefits In Diabetes Mellitus: A Meta-Analysis

Association Between Physical Activity and Colorectal Cancer Risk and Prognosis: A Meta-Analysis

The Relationship Between Anti-Hypertensive Drugs and Cancer: Anxiety to be Resolved in Urgent

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies.

Antihypertensive Medications Are Associated with the Risk of Kidney and Bladder Cancer: a Systematic Review and Meta-Analysis.

Use of Antihypertensive Drugs and Risk of Malignant Melanoma: A Meta-analysis of Observational Studies.

Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer

Association of ACEIs/ARBs therapy with digestive system neoplasms: a meta-analysis

Long-term exposure to antihypertensive drugs and the risk of cancer occurrence: evidence from a large population-based study

The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies.